Integral Health Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-120,000
| Closed | -$12.2M | – | 95 |
|
|
2023
Q2 | $12.2M | Buy |
120,000
+49,000
| +69% | +$5M | 1.52% | 23 |
|
|
2023
Q1 | $6.46M | Sell |
71,000
-14,000
| -16% | -$1.27M | 1.3% | 33 |
|
|
2022
Q4 | $3.23M | Buy |
+85,000
| New | +$3.23M | 0.68% | 47 |
|
|
2022
Q3 | – | Sell |
-104,369
| Closed | -$3.17M | – | 84 |
|
|
2022
Q2 | $3.17M | Buy |
104,369
+69,369
| +198% | +$2.11M | 0.65% | 50 |
|
|
2022
Q1 | $1.15M | Sell |
35,000
-68,000
| -66% | -$2.23M | 0.3% | 62 |
|
|
2021
Q4 | $2.72M | Buy |
103,000
+68,000
| +194% | +$1.79M | 0.75% | 43 |
|
|
2021
Q3 | $3.52M | Sell |
35,000
-7,000
| -17% | -$704K | 1.01% | 43 |
|
|
2021
Q2 | $5.94M | Sell |
42,000
-2,000
| -5% | -$283K | 1.64% | 26 |
|
|
2021
Q1 | $4.39M | Sell |
44,000
-6,000
| -12% | -$598K | 1.25% | 33 |
|
|
2020
Q4 | $6.18M | Buy |
50,000
+10,000
| +25% | +$1.24M | 1.84% | 23 |
|
|
2020
Q3 | $3.9M | Buy |
+40,000
| New | +$3.9M | 1.19% | 29 |
|